DENVER, March 17, 2022 /PRNewswire/ – Medicine Man Technologies, Inc., dba Schwazze, (OTCQX: SHWZ) (“Schwazze” or the “Company”), is pleased to announce that it has received final approval from the NEO Exchange (the “NEO”) to list the Company’s common shares onto the NEO, a tier one Canadian stock exchange based in Toronto, Ontario. The common shares are expected to begin trading on the NEO on March 23, 2022, under the symbol SHWZ.
Schwazze is currently listed on the OTCQX and believes that the additional listing onto the NEO, enabling the Company’s common shares to be traded on a senior exchange in Canada, will provide additional exposure to an increased number of retail and institutional investors.
“The NEO listing is an important milestone for Schwazze and provides an additional platform as we bring our story to new investor audiences, and we continue to execute our proven growth playbook as an MSO with a differentiated regional position.” commented Nancy Huber, Chief Financial Officer of Schwazze. “The NEO is now setting the pace for Cannabis companies who want to attract the right institutional attention and increase their liquidity.”
Schwazze (OTCQX: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high- performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices. Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.
About the Neo Exchange Inc.
The Neo Exchange Inc. is Canada’s Tier 1 stock exchange for the innovation economy, bringing together investors and capital raisers within a fair, liquid, efficient, and service-oriented environment. Fully operational since June 2015, NEO puts investors first and provides access to trading across all Canadian-listed securities on a level playing field. NEO lists companies and investment products seeking an internationally recognized stock exchange that enables investor trust, quality liquidity, and broad awareness including unfettered access to market data.
This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,” “continue,” “predicts,” or similar words. Forward-looking statements include the Company’s expectations regarding the listing date for its common shares on the NEO and the expected benefits of listing on the NEO. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses, including the acquisition described in this press release, and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, and (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such lawsListing on the NEO is subject to satisfaction of the final listing conditions. The benefits of listing on the NEO depend on increased liquidity for the Company’s shareholders and exposure due to listing on a senior exchange. Such benefits may not be realized. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.
SOURCE Medicine Man Technologies, Inc.